text
"['\n1. 요약재무정보\n1) 요약 연결재무제표\n주식회사 에이프로젠과 그 종속기업\n(단위 : 원)\n구 \xa0 \xa0 \xa0분\n제 53(당) 분기\n제 52(전)기\n제 51(전전)기\n1. 요약 재무상태표\n(2023년 09월 30일 현재)\n(2022년 12월 31일 현재)\n(2021년 12월 31일 현재)\n\u3000유동자산\n185,617,309,401\n211,577,633,197\n103,099,363,353\n\u3000\u3000현금및현금성자산\xa0\n22,363,086,181\n43,069,501,023\n15,893,503,873\n\u3000\u3000매출채권 및 기타유동채권\xa0\n81,488,379,107\n92,305,904,494\n56,990,094,596\n\u3000\u3000기타유동금융자산\n4,390,000,000\n4,390,000,000\n4,000,000,000\n\u3000\u3000재고자산\xa0\n70,288,229,975\n61,466,652,770\n23,257,262,751\n\u3000\u3000기타유동자산\xa0\n5,832,825,128\n3,540,080,006\n2,366,947,893\n\u3000\u3000당기법인세자산\n1,254,789,010\n6,805,494,904\n591,554,240\n\u3000비유동자산\n411,557,736,162\n388,275,648,544\n374,547,035,232\n\u3000\u3000기타비유동채권\xa0\n1,630,687,794\n3,503,218,593\n2,361,211,951\n\u3000\u3000기타비유동금융자산\xa0\n10,530,141,645\n3,298,173,979\n20,745,377,859\n\u3000\u3000관계기업투자주식\xa0\n0\n0\n34,040,936,160\n\u3000\u3000유형자산\n363,190,872,129\n365,099,958,632\n314,479,014,477\n\u3000\u3000무형자산\xa0\n35,224,262,915\n13,419,092,648\n2,633,095,260\n\u3000\u3000투자부동산\xa0\n55,546,131\n2,142,800,421\n57,686,814\n\u3000\u3000기타비유동자산\xa0\n335,889,973\n149,562,922\n229,712,711\n\u3000\u3000이연법인세자산\n590,335,575\n662,841,349\n0\n\u3000자산총계\n597,175,045,563\n599,853,281,741\n477,646,398,585\n[유동부채]\n147,556,450,487\n89,933,338,793\n421,928,721,268\n[비유동부채]\n19,249,272,055\n48,917,566,485\n56,524,120,087\n부 채 총 계\n166,805,722,542\n138,850,905,278\n478,452,841,355\n[지배기업의 소유주지분]\n166,965,616,910\n215,092,354,198\n2,163,178,265\n\xa0 자본금\n129,918,629,000\n126,834,427,500\n260,351,437,000\n\xa0 자본잉여금\n469,081,672,174\n431,640,908,638\n46,794,485,822\n\xa0 기타자본구성요소\n(72,027,036,892)\n(55,719,498,278)\n(113,403,240,100)\n\xa0 기타포괄손익누계액\n5,883,501,586\n5,341,081,201\n886,575,619\n\xa0 이익잉여금(결손금)\n(365,891,148,958)\n(293,004,564,863)\n(192,466,080,076)\n[비지배지분]\n263,403,706,111\n245,910,022,265\n(2,969,621,035)\n자 본 총 계\n430,369,323,021\n461,002,376,463\n(806,442,770)\n2. 요약 포괄손익계산서\n(2023.1.1~2023.09.30)\n(2022.1.1~2022.12.31)\n(2021.1.1~2021.12.31)\n매출액\n113,189,964,972\n78,349,308,044\n26,295,794,076\n영업이익(손실)\n(63,897,957,815)\n(119,344,687,080)\n(94,636,240,572)\n당기순이익(손실)\n(70,256,570,056)\n(116,084,862,495)\n(119,229,369,806)\n- 지배기업소유주지분순이익(손실)\n(72,936,366,794)\n(98,656,711,257)\n(93,920,246,242)\n- 비지배지분순이익(손실)\n2,679,796,738\n(17,428,151,238)\n(25,309,123,564)\n기본주당순이익(손실)\n(312)\n(490)\n(541)\n희석주당순이익(손실)\n(312)\n(497)\n(541)\n연결에 포함된 회사 수\n8\n8\n2\n2) 요약 별도재무제표\n주식회사 에이프로젠\n(단위 : 원)\n구 \xa0 \xa0 \xa0분\n제 53(당) 분기\n제 52(전)기\n제 51(전전)기\n1. 요약 재무상태표\n(2023년 09월 30일 현재)\n(2022년 12월 31일 현재)\n(2021년 12월 31일 현재)\n\u3000유동자산\n42,782,435,819\n50,968,288,531\n26,082,180,411\n\u3000\u3000현금및현금성자산\xa0\n10,344,430,205\n18,987,859,298\n10,148,420,282\n\u3000\u3000매출채권 및 기타유동채권\xa0\n12,696,300,224\n16,342,248,302\n10,334,726,806\n\u3000\u3000기타유동금융자산\xa0\n4,000,000,000\n4,000,000,000\n4,000,000,000\n\u3000\u3000당기법인세자산\n916,360,990\n1,368,527,113\n178,643,840\n\u3000\u3000재고자산\n12,161,349,303\n8,670,838,898\n83,916,352\n\u3000\u3000기타유동자산\n2,663,995,097\n1,598,814,920\n1,336,473,131\n\u3000비유동자산\n562,623,257,350\n506,436,399,541\n180,143,086,542\n\u3000\u3000기타비유동채권\xa0\n60,657,392,211\n86,274,848,465\n1,673,470,701\n\u3000\u3000기타비유동금융자산\xa0\n69,104,192,626\n534,939,682\n20,745,377,859\n\u3000\u3000종속기업 투자주식\n273,965,107,831\n278,377,956,648\n101,056,306,494\n\u3000\u3000관계기업 투자주식\xa0\n-\n-\n34,040,936,160\n\u3000\u3000유형자산\n33,010,660,339\n35,869,499,363\n22,029,697,305\n\u3000\u3000무형자산\n125,550,926,600\n103,108,366,216\n309,898,498\n\u3000\u3000투자부동산\xa0\n55,546,131\n2,142,800,421\n57,686,814\n\u3000\u3000기타비유동자산\xa0\n279,431,612\n127,988,746\n229,712,711\n\u3000자산총계\n605,405,693,169\n557,404,688,072\n206,225,266,953\n[유동부채]\n300,739,794,177\n224,980,405,151\n62,009,526,849\n[비유동부채]\n36,385,239,162\n36,638,117,290\n33,856,803,504\n부채총계\n337,125,033,339\n261,618,522,441\n95,866,330,353\n\xa0 자본금\n129,918,629,000\n126,834,427,500\n260,351,437,000\n\xa0 자본잉여금\n401,472,228,338\n388,536,952,776\n4,172,827,662\n\xa0 기타자본구성요소\n(90,838,065,583)\n(91,737,789,774)\n(113,403,240,100)\n\xa0 기타포괄손익누계액\n3,756,901\n3,756,901\n(61,803)\n\xa0 이익잉여금(결손금)\n(172,275,888,826)\n(127,851,181,772)\n(40,762,026,159)\n자본총계\n268,280,659,830\n295,786,165,631\n110,358,936,600\n종속기업 투자주식 평가방법\n원가법\n원가법\n원가법\n관계기업 및 공동기업 투자주식 평가방법\n원가법\n원가법\n원가법\n2. 요약 포괄손익계산서\n(2023.1.1~2023.09.30)\n(2022.1.1~2022.12.31)\n(2021.1.1~2021.12.31)\n매출액\n59,643,656,893\n34,794,714,037\n8,153,186,716\n영업이익(손실)\n(24,110,978,891)\n(53,344,690,289)\n(39,298,465,121)\n당기순이익(손실)\n(44,547,753,955)\n(87,191,900,308)\n(53,677,952,021)\n기본주당순이익(손실)\n(190)\n(433)\n(309)\n희석주당순이익(손실)\n(204)\n(453)\n(309)\n* (주)에이프로젠(비상장회사)은 관계기업인 ㈜에이프로젠메디신과 2022년 7월 18일자로 합병하였으며(합병의 회계기준일인 합병기일은 2022년 7월 15일), 법률적으로는 ㈜에이프로젠메디신이 (주)에이프로젠(비상장회사)을 흡수합병하나 회계상으로는 (주)에이프로젠(비상장회사)이 ㈜에이프로젠메디신을 흡수합병하는 역합병 형태의 사업결합 회계처리를 하였으므로, (주)에이프로젠(비상장사)를 합병회사로 하여, 상기 요약(연결)재무정보를 위와 같이 작성하였습니다. \n']"
